Psychopharmacology Consulting

Helping Australian bio-tech companies to develop new medications for psychiatric disorders.

How we can help

Below are some of the pressure points for early/mid-stage drug development, which we have expertise in helping with.

Choosing the best preclinical models for lead selection and optimisation

Evidence-based models which are sensitive to the mechanism of action of your molecules, or to the phenotype you are seeking.

Finding the ideal contract research organisations

Matching you with CRO's with the capabilities, reliability, flexibility, dedicated relationships, cost, and experience, suited to your goals and needs.


Planning early for clinical translation

Anticipating translation hurdles for your molecules or indication, and optimise early stage development to enable smooth translation to the clinic.

Taking advantage of non-dilutive funding opportunities

Strategies to be eligible and competitive for non-dilutive grants, and finding the appropriate academic and institutional partners

Questions?

Contact nick@psychopharmacology.com.au to discuss how we can optimise the development and translation of your molecules.